cancer risk seemed lower for those who breastfed (adjusted OR = 0.04; 95% CI: 0.01, 0.18). There was no significance for early age at first full-term birth (adjusted OR = 1.96; 95% CI: 0.97, 3.96; p = 0.061), and urban residence carried no increased odds of breast cancer either (p = 0.201). Conclusion: Breastfeeding seems to be associated with reduced odds of breast cancer.
Introduction
Although in Uganda women have a lower incidence of breast cancer than in Canada, the USA, and Western Europe [1] , the disease rate is rising steeply; it has nearly tripled in a short period of time from 11 per 100,000 in 1962 to 31 per 100,000 in 2006, and it is predicted to become the commonest non-HIV-related malignancy among Ugandan women within less than a decade [2] . The factors fueling this rapid rise are not fully known. Exploring risk factors in this setting may provide some clues.
There is a paucity of studies that have examined risk factors for breast cancer in Ugandan women, and even fewer have examined the association with reproductive factors in sub-Saharan Africa [3, 4] . In Uganda, parity and breastfeeding were examined in one study done 20 years ago, suggesting that parity was not protective but breastfeeding was [5] .
In this study, we examined parity, breastfeeding, late age at first full-term birth (AFB), alcohol use, combined oral contraceptive (CoC) use, rural residence, and body mass index (BMI) as possible risk factors associated with breast cancer.
Study Site Context
Uganda is a landlocked country straddling the equator in East Africa. The country's area is 241,040 km 2 and it currently has a population of 32,709,865 people [6] . With a total fertility rate of 6.7 births per woman -the second highest in the world -Uganda is due to double its population by 2037 (starting with the numbers from 2006) [7] . Its capital, Kampala, is a city of 1.4 million people located in the south-central region of the country. Despite achieving a 5.8% gross domestic product growth rate in 2010, almost one third of the country still live in poverty (defined as living on less than USD 1.25 per day) [5] . A total of 85% of the population live in rural areas, and most of them work in the agriculture sector [8] . Uganda ranks 143rd among the 169 countries surveyed for the 2010 Human Development Index [9, 10] . Life expectancy has slowly been increasing to its current level of 53 years, although half of the population is between the ages of 0 and 14 years. The Ugandan health system was developed by public and private providers; most health care is free. Referrals for cancer care are mostly sent to the Mulago National Referral Hospital and the Uganda Cancer Institute (UCI).
Methods

Design
This is a case-control study.
Setting
The study was conducted at two tertiary care institutions: the Mulago National Referral Hospital and the UCI. Together the two sites may receive up to 200 incident cases per year; however, there may be high dropout rates.
Study Sample
Cases were identified prospectively from women with a confirmed histological diagnosis of invasive breast cancer during the study period from September 2011 to December 2012. Controls were randomly selected from patients who visited other units or departments, especially surgical outpatient units where post-traumatic and other surgical conditions are attended to; obstetrics and gynecology wards were excluded. All eligible controls had no cancer ailments; they were not chosen from the UCI. The controls were considered to come from the same catchment area as the cases. The clients were ethnically and socioeconomically diverse and represented the diversity of the Ugandan population and the patient population that comes to the Mulago Hospital and the 
Inclusion Criteria
Controls were female, without any type of cancer as determined from their medical histories and general physical examination, and able to give informed written consent.
Study Variables
The following variables were considered: age, area of residence (rural or urban), BMI, and alcohol consumption. In addition, parity, menarche, AFB, CoC use, and breastfeeding were included as reproductive factors.
Age was categorized as ≤ 50 or >50 years (a proxy for menopausal status). BMI was determined by measuring weight in kilograms per height in meters squared. Alcohol use was assessed through history taking, and the response was either 'yes' or 'no' (amounts were not quantified). Parity was determined by the number of pregnancies a participant had ever had. Menarche was defined as the age at which the first menses occurred. AFB was completed years when the first full-term birth ( ≥ 37 weeks of gestation) occurred. For breastfeeding it was assessed whether or not it was done, as well as its duration if performed. All these parameters were gathered through history taken from the study participants using a precoded and pretested questionnaire.
Laboratory Methods and Quality Assurance
Hematoxylin and eosin staining was performed to confirm the diagnosis of invasive breast cancer. The histological type and grade were determined. All the histological slides were investigated by an experienced consultant pathologist and laboratory technicians, and the tumors were classified according to the Nottingham modification of the Scarff-Bloom-Richardson criteria [11] . Based on histology, the tumors were classified into the following groups: invasive ductal carcinoma (not otherwise specified), lobular, medullary, papillary, and colloid.
Data Analysis
Demographic factors and potential confounding variables were compared between cases and controls using χ 2 tests for categorical variables. Logistic regression models were used to examine the relationship of breast cancer risk to the selected reproductive factors. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed as measures of association from the logistic model. A multivariable logistic regression model was used and included the following variables: age, parity, breastfeeding, menarche, AFB, CoC use, and BMI. Statistical significance was considered if p ≤ 0.05.
Data were occasionally missing for all variables; no further analyses were done for missing data. In the final analysis, women who had never given birth were excluded.
Ethical Considerations
The study was approved by the Institutional Review Boards of Makerere University and the Uganda National Council of Science and Technology (UNCST) and thus meets the standards of the Declaration of Helsinki in its revised version of 1975 and its amendments of 1983, 1989, and 1996. All participants gave informed written consent.
Results
Of the 350 women recruited in this study, 113 were cases and 237 controls ( fig. 1 ). Table 1 shows the overall demographic characteristics as well as reproductive and nonreproductive factors. The mean age was 47.5 years (SD 14) for the cases and 45.5 years (SD 14.1) for the controls.
The distribution by regions of the country was not significantly different. There were more multiparous ( ≥ 5) women among the controls. There were no significant differences with regard to menarche and BMI between the groups. There were more women having their fullterm birth in the age brackets of 13-19 and 20-24 years among the controls. More women used CoCs among the controls, and more women breastfed among the controls. All significant differences were considered potential confounders and were adjusted for in the subsequent ana lyses. A factor associated with increased odds of cancer, though not statistically significantly, was AFB <20 relative to ≥ 20 years (adjusted OR = 1.96; 95% CI: 0.97, 3.96; p = 0.061), while ever having breastfed was associated with reduced odds of being a case (adjusted OR = 0.04; 95% CI: 0.01, 0.18). Use of alcohol (adjusted OR = 0.57; 95% CI: 0.29, 1.11) had no significant association with being a cancer case ( table 2 ).
For women aged ≥ 50 years, the odds of having cancer were lower (though not significantly so) among the ever CoC users compared to the never CoC users (adjusted OR = 0.30; 95% CI: 0.07, 1.27). For the never CoC users, the odds of having cancer were higher among the <50-year-olds compared to the women aged ≥ 50 years (adjusted OR = 1.91; 95% CI: 0.98, 3.74). However, these associations were not statistically significant.
There was an interaction between age and ever CoC use for the association between cancer and age. The OR of having cancer when younger women (<50 years) were compared to older ones ( ≥ 50 years), and ever CoC use to never CoC use, was 0.13 (95% CI: 0.02, 0.83). These data suggest that in women aged ≥ 50 years, the risk for breast cancer in the group that had ever used CoC was significantly lower than in the group that had never used them ( table 2 ). 
Discussion
While the risk factors investigated in this study are those that have been well established in many diverse high-risk as well as low-risk populations, including some in Africa, very few studies have specifically targeted women in Uganda and East Africa [4] . There are indications that the consensus on associations of breast cancer with some risk factors is not consistent [12] . With the additional knowledge that the incidence of breast cancer in Uganda is increasing at an unprecedented rate of 4% per annum [2] and the emerging picture of biological and epidemiological disparities in breast cancer between highand low-income countries [13] [14] [15] , there will often be a need to re-explore these associations between breast cancer and previously known and/or newly suspected risk factors.
We therefore set out to explore commonly known risk factors associated with breast cancer among Ugandan women presenting at the two largest cancer referral institutions. We found that CoC use had a paradoxical, inverse relationship to breast cancer in women <50 years of age (premenopausal) who had ever used CoCs. They had lower odds of being a case than older women (postmenopausal) who had never used CoC. The role of CoC in oncogenesis is controversial or not wholly conclusive. One of the reasons is that the etiology of breast cancer is multifactorial and cannot be directly linked to any single factor, including estrogen. The epidemiological literature supports a highly complex interplay between different exposures and host characteristics as well as between exogenous and endogenous hormones and the individual's makeup [16] .
There are two major potential mechanisms that have been postulated by which estrogen increases the risk of breast cancer: the first mechanism is stimulation of estrogen receptor-mediated transcription that results in cell proliferation, and the second mechanism is direct carcinogenesis through metabolic activation and direct binding of DNA. There is also a view that these two mechanisms act in an additive or even synergistic manner [17, 18] . A large study published in the Lancet [19] involving over 150,000 women suggested that CoC use increased the risk of breast cancer. In several other studies that followed, no significant risk was found, especially with the use of newer CoCs, and there was a minimal risk with older CoCs [16] . In a report on a UK cohort of 46,000 women published in 2007 spanning a 36-year period, there was no evidence of a substantially increased risk of any cancer, including breast cancer [20] . Noteworthy, there is no literature pertaining to women in sub-Saharan Africa. In the studies cited here, the number of black women included was very small. The IARC statement from 2005 that CoCs are classified as a group 1 carcinogen (the highest ranking) for breast and cervical cancers [21] only added to the inconsistencies in proof. The explanation given for the level of cancer reduction seen in different parts of the world depends on factors such as the level of CoC usage, duration of use, age at stopping, and incidence of different cancers. More work is needed to quantify the likely balance between cancer risks and benefits in different parts of the world, including effects on mortality [20] . Treatment by the practicing physician is to be selective and specific to the patient's risk; women with a family history of breast cancer among 1st-degree relatives and with premalignant lesions should not take CoCs.
We found that coming from an urban setting did not lead to a higher risk for breast cancer than residing in a rural setting. We had anticipated that there would be differences between rural and urban settings due to perceived differences in lifestyle in terms of diet and other environmental factors. Increasing urbanization is suggested to be associated with an increased risk for breast cancer [22] .
High parity was not protective against breast cancer. This is contrary to what we had anticipated [12, 23, 24] . In this study, the parous women had no lower odds of being a case (having breast cancer) than the nulliparous ones. The relationship between parity and breast cancer is known to be complex [15] . However, it is intricately related to estrogen exposure and interruption [3, 25] . The interruption of estrogen synthesis during pregnancy is known to be protective against breast cancer, since estrogen is a driver of cellular proliferation [12, 24, 25] .
AFB was marginally related to increased odds of breast cancer (p = 0.061). The older the women were before having their first full-term birth, the higher the odds were of having breast cancer. This trend fits with the known physiological evidence of estrogen interruption, even though it was only inconclusively demonstrated here. Late pregnancy means a prolonged period of uninterrupted estrogen exposure. We also found that 70% of the Ugandan women had their menarche before the age of 17 years; the majority were multiparous (64%) and had had ≥ 4 live births, and most (90%) had breastfed their babies.
Overall, these factors could contribute to the relatively low breast cancer incidence seen in Uganda as compared to richer nations [2] , even if they do not seem to explain the fact that the incidence of breast cancer has nearly tri- pled over the last four decades in Uganda. It may therefore be worthwhile exploring the trends for these factors (menarche, parity, and breastfeeding) extensively over the past decades in Uganda.
BMI showed an inverse relationship to the odds of having breast cancer, though it was not statistically significant. This seemingly paradoxical relationship could be explained by the possibility that the cases had lost some of their body mass during the period preceding the diagnosis.
Breastfeeding has been inversely related to breast cancer risk in the general population [19] and it seemed protective against breast cancer in this study. The effect appeared to be greater than previously documented [26] ; perhaps this was due to the fact that only a small number of women did not breastfeed. In Uganda, most women who bear children breastfeed them, thus making the task of getting sufficient numbers to robustly estimate the protective effect of breastfeeding a challenge. In the literature, only a slight reduction in the risk of breast cancer was reported among premenopausal women with increasing cumulative duration of lactation. There seems to be no evidence to support a reduction in the risk of breast cancer among postmenopausal women in many of the studies [27] [28] [29] [30] [31] [32] [33] [34] ; in other studies, no benefit was found [12, 23, 34] . It is also likely that the significant protective effect seen in this study is due to the fact that a significant number of participants were premenopausal. Lactation as a method for prevention of breast cancer has a strong appeal, since it is a potentially modifiable factor [26] . It is possible to strongly encourage women to breastfeed early and for a long period of time.
In order to promote public health in diverse populations and to provide further insight into breast cancer etiology, research needs to focus on multicultural differences and similarities in relation to the risk of cancer [35] . Therefore, a larger multi-country study to elucidate the protective effect of breastfeeding on breast cancer occurrence among pre-and postmenopausal African women is warranted. Breastfeeding is hypothesized to reduce the risk of breast cancer primarily through two mechanisms: differentiation of breast tissue and reduction of the lifetime number of ovulatory cycles (exposure to ovarian hormones) [24] .
Limitations of This Study
Selection errors could have arisen from the possibility of leaving out an undiagnosed breast cancer early. However, the effect of this is likely to have been small given that the general population risk for breast cancer in Uganda is 1 in 3,000. The disease history was self-reported and therefore subject to recall bias; however, women mostly report their parity, breastfeeding, and alcohol use histories reliably [4] . Although reporting of the age at menarche may be less accurate, it should not have been reported any differently by cases and controls. The fact that there were only a small number of women who did not breastfeed or who consumed alcohol may have introduced a bias, though this was controlled for in the analysis. The lack of data on the duration (and amount where applicable) of exposure to risks such as tobacco smoking, alcohol use, CoC use, and breastfeeding is a weakness; this, however, might be dealt with in follow-up studies in this environment.
Conclusion
Breastfeeding seems to be associated with lower odds of breast cancer in this cohort of Ugandan women, and CoC use led to reduced odds of cancer in women <50 years of age.
